Close
Nordic 9Nordic 9

Reference Capital (investor - Venture Capital)

Switzerland referencecap.com
See something wrong or missing? Let us know
Offices:Geneva

Reference Capital (formerly Genevest SA), founded in 1983, is a Swiss-based private investments advisor with one of the longest track records in Europe.

Average round investment:50.9M USD
Average number per year:2.0
Distribution: 2020 (2)
Portfolio companies: Switzerland T3 PharmaceuticalsUnited Kingdom Monzo
Mostly invests in: Switzerland Switzerland (1) Pharma (1)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Reference Capital

Name Criteria
United States General Atlantic
87%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Health services, Pharma, Financial Services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: Switzerland, United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
France Seventure Partners
82%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma, Financial Services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.9
Sweden AP4 - Fjärde AP-fonden
82%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma, Financial Services
  • Similar business models: B2B, B2C (Retail)
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Arab Emirates Mubadala Capital
81%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Health services, Pharma, Financial Services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.7
United Kingdom Kreos Capital
80%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma, Financial Services
  • Similar business models: B2B, B2C (Retail)
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Sweden EQT Partners
78%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Health services, Pharma, Financial Services
  • Similar business models: B2B, B2C (Retail)
  • Average number of deals per year: 3.5
  • Active last 12 months: Yes
France Idinvest Partners
78%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma, Financial Services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom
  • Average number of deals per year: 4.3
Finland Sampo Group
77%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Health services, Pharma, Financial Services
  • Similar business models: B2B, B2C (Retail)
  • Average number of deals per year: 2.5
Singapore Temasek
77%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Health services, Financial Services
  • Similar business models: B2B, B2C (Retail)
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
United States Bain Capital
77%
  • Range for average deal size: 50M+ USD
  • Similar verticals: Health services, Pharma, Financial Services
  • Similar business models: B2B
  • Common investees countries: Switzerland, United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Top